The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
The Comparison of the Initial TIMI Flow Grade in Acute ST-Elevation Myocardial Infarction Patients Receiving Ticagrelor vs. Clopidogrel before Undergoing Primary Percutaneous Coronary Intervention: A Prospective Cohort Study
CONCLUSION: In STEMI patients who were candidates for primary PCI, ticagrelor administration led to a better initial TIMI flow grade compared to clopidogrel.PMID:38348469 | PMC:PMC10861275 | DOI:10.1155/2024/6632656 (Source: Cardiology Research and Practice)
Source: Cardiology Research and Practice - February 13, 2024 Category: Cardiology Authors: Amin Elahifar Ali Rafati Mohammad Javad Alemzadeh-Ansari Yeganeh Pasebani Behshad Naghshtabrizi Younes Mohammadi Seyed Kianoosh Hosseini Source Type: research
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262.ABSTRACTBACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles.METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular...
Source: cmaj - February 12, 2024 Category: General Medicine Authors: Anxin Wang Xue Tian Xuewei Xie Hao Li Philip M Bath Jing Jing Jinxi Lin Yilong Wang Xingquan Zhao Zixiao Li Liping Liu Yongjun Wang Xia Meng Source Type: research
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262.ABSTRACTBACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles.METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular...
Source: Canadian Medical Association Journal - February 12, 2024 Category: General Medicine Authors: Anxin Wang Xue Tian Xuewei Xie Hao Li Philip M Bath Jing Jing Jinxi Lin Yilong Wang Xingquan Zhao Zixiao Li Liping Liu Yongjun Wang Xia Meng Source Type: research
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262.ABSTRACTBACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles.METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular...
Source: cmaj - February 12, 2024 Category: General Medicine Authors: Anxin Wang Xue Tian Xuewei Xie Hao Li Philip M Bath Jing Jing Jinxi Lin Yilong Wang Xingquan Zhao Zixiao Li Liping Liu Yongjun Wang Xia Meng Source Type: research
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262.ABSTRACTBACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles.METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular...
Source: Canadian Medical Association Journal - February 12, 2024 Category: General Medicine Authors: Anxin Wang Xue Tian Xuewei Xie Hao Li Philip M Bath Jing Jing Jinxi Lin Yilong Wang Xingquan Zhao Zixiao Li Liping Liu Yongjun Wang Xia Meng Source Type: research
Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial
CMAJ. 2024 Feb 11;196(5):E149-E156. doi: 10.1503/cmaj.231262.ABSTRACTBACKGROUND: Elevated homocysteine levels are associated with increased blood coagulation and platelet activity and may modulate the response to antiplatelet therapies. We aimed to investigate the effects of homocysteine levels on the efficacy and safety of ticagrelor-acetylsalicylic acid (ASA) versus clopidogrel-ASA among patients with minor stroke or transient ischemic attack who carried CYP2C19 loss-of-function alleles.METHODS: We conducted a post hoc analysis of the CHANCE-2 (The Clopidogrel in High-risk Patients with Acute Nondisabling Cerebrovascular...
Source: cmaj - February 12, 2024 Category: General Medicine Authors: Anxin Wang Xue Tian Xuewei Xie Hao Li Philip M Bath Jing Jing Jinxi Lin Yilong Wang Xingquan Zhao Zixiao Li Liping Liu Yongjun Wang Xia Meng Source Type: research
